denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Symposia: ASH-a-Palooza
Program: Trainee Activities and Services
Hematology Disease Topics & Pathways:
Sickle Cell Disease, Clinical Practice (Health Services and Quality), Diversity, Equity, and Inclusion (DEI), Hemoglobinopathies, Diseases
Hematology Disease Topics & Pathways:
Sickle Cell Disease, Clinical Practice (Health Services and Quality), Diversity, Equity, and Inclusion (DEI), Hemoglobinopathies, Diseases
Friday, December 6, 2024: 1:30 PM-3:50 PM
Café Sevilla Restaurant
(Gaslamp Quarter)
Panelists:
Susan Elizabeth Creary, MD, MSc, Nationwide Children's Hospital Research Institute
,
Lewis L Hsu, MD, PhD, University of Illinois at Chicago
,
Jacquelyn Powers, MD, Baylor College of Medicine/Texas Children's Hospital
,
Deepika S. Darbari, MBBS, MS, Children's National Hospital
and
Meghan D Drayton Jackson, DO, Riley Hospital for Children
Disclosures:
Hsu: Nemours/DuPont Children’s Hospital: Consultancy; Abt Assoc: Consultancy; DisperSol: Consultancy; Hilton HPC: Consultancy; Asklepion: Research Funding; Pfizer: Research Funding; GBT: Research Funding; Aruvant: Other: data safety monitoring, ended 2023. Powers: Pharmacosmos LLC: Membership on an entity's Board of Directors or advisory committees. Darbari: Pfizer: Research Funding.
Trainees have the opportunity to meet with leaders in the field. Trainees sign up for a one-on-one Blood Buddy ten-minute mentoring session with a faculty member. Blood Buddies are experts in various hematology topic areas. This is an excellent opportunity for trainees to network with and receive mentorship from seasoned faculty. There are 3 Blood Buddies sessions at the event. Although the speakers roles are marked as primary and alternate, multiple speakers may be asked to present on the same topic if that topic will be repeated in the following sets of Blood Buddies. The featured topics are: Adult Clinical Malignant Hematology; Pediatric Clinical Malignant Hematology; Adult Clinical Classical Hematology; Pediatric Clinical Classical Hematology; BMT Pediatric and Adult; Quality Improvement; Medical Education; PhD/Laboratory; Diversity, Equity, and Inclusion; International Medical Graduates; Future of Hematology (Artificial Intelligence); Industry Career Pathway; Federal Career Pathway.